Literature DB >> 12460870

Differentiation between obesity and insulin resistance in the association with C-reactive protein.

Tracey McLaughlin1, Fahim Abbasi, Cindy Lamendola, Lynn Liang, Gerald Reaven, Patricia Schaaf, Peter Reaven.   

Abstract

BACKGROUND: Plasma C-reactive protein (CRP) concentrations are increased in obese and/or hyperinsulinemic individuals. The goal of this study was to determine if the relation between insulin resistance and CRP was independent of obesity. METHODS AND
RESULTS: Plasma CRP concentrations were measured before and after 3 months of calorie restriction in 38 healthy, obese women. Steady-state plasma glucose (SSPG) concentration during a 180-minute infusion of octreotide, glucose, and insulin was used to stratify participants into insulin-resistant (IR, n=20) or insulin-sensitive (n=18) groups, similar in terms of mean age (46+/-2 versus 44+/-2 years), body mass index (32.0+/-0.4 versus 31.4+/-0.3 kg/m2), and waist circumference (96+/-2 versus 95+/-2 cm). Mean CRP (0.39+/-0.08 versus 0.12+/-0.03 mg/dL, P=0.003) concentrations were higher in the IR group, as were day-long plasma glucose and insulin responses (P<0.001). There was a significant correlation at baseline between CRP and day-long plasma integrated insulin response (r=0.47, P=0.001) but not between CRP and body mass index (r=0.14) or waist circumference (r=0.10). Weight loss was similar in the two groups (8.7+/-0.9 versus 8.4+/-0.8 kg) but was associated with significant (P<0.001) decreases in SSPG and CRP concentrations in the IR group only. Regression analysis showed that SSPG and day-long plasma insulin response were the only significant predictors of CRP concentration.
CONCLUSIONS: CRP concentrations are elevated predominantly in obese individuals who are also insulin resistant and fall in parallel with weight loss-associated improvements in insulin resistance. The relation between CRP concentrations and insulin resistance is independent of obesity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12460870     DOI: 10.1161/01.cir.0000041046.32962.86

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  65 in total

Review 1.  C-reactive protein: a critical update.

Authors:  Mark B Pepys; Gideon M Hirschfield
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 2.  The insulin resistance syndrome.

Authors:  Gerald M Reaven
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

Review 3.  Inflammation and conjugated linoleic acid: mechanisms of action and implications for human health.

Authors:  M A Zulet; A Marti; M D Parra; J A Martínez
Journal:  J Physiol Biochem       Date:  2005-09       Impact factor: 4.158

4.  Metabolic syndrome and sleep apnea.

Authors:  I Kostoglou-Athanassiou; P Athanassiou
Journal:  Hippokratia       Date:  2008-04       Impact factor: 0.471

5.  Relationship of high-sensitive C-reactive protein with cardiovascular risk factors, clinical presentation and angiographic profile in patients with acute coronary syndrome: an Indian perspective.

Authors:  Sharad Gupta; Vitull K Gupta; Rupika Gupta; Sonia Arora; Varun Gupta
Journal:  Indian Heart J       Date:  2013-05-16

6.  Diet-induced obesity is associated with hyperleptinemia, hyperinsulinemia, hepatic steatosis, and glomerulopathy in C57Bl/6J mice.

Authors:  Undi Hoffler; Kristen Hobbie; Ralph Wilson; Re Bai; Akef Rahman; David Malarkey; Greg Travlos; Burhan I Ghanayem
Journal:  Endocrine       Date:  2009-08-11       Impact factor: 3.633

7.  A better parameter in predicting insulin resistance: obesity plus elevated alanine aminotransferase.

Authors:  Ping-Hao Chen; Jong-Dar Chen; Yu-Cheng Lin
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

8.  A QTL on 12q influencing an inflammation marker and obesity in white women: the NHLBI Family Heart Study.

Authors:  Jun Wu; James S Pankow; Russell P Tracy; Kari E North; Richard H Myers; Mary E Feitosa; Michael A Province; Ingrid B Borecki
Journal:  Obesity (Silver Spring)       Date:  2008-12-25       Impact factor: 5.002

Review 9.  The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  R Kahn; J Buse; E Ferrannini; M Stern
Journal:  Diabetologia       Date:  2005-09       Impact factor: 10.122

Review 10.  Tumour biology of obesity-related cancers: understanding the molecular concept for better diagnosis and treatment.

Authors:  Seong Lin Teoh; Srijit Das
Journal:  Tumour Biol       Date:  2016-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.